Pharmacological roles of the large-conductance calcium-activated potassium channel

Current Topics in Medicinal Chemistry

Volumn 6, Issue 10, 2006, Pages 1025-1030

  Wu, Sheng Nan ^a   Wu, Adonis Z ^a   Lin, Ming Wei ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

BKCa channel inhibitor; BKCa channel opener; Ca2+ activated K+ current; Intracellular Ca2+; Large conductance Ca2+ activated K+ (BKCa) channel

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; CAFFEIC ACID PHENETHYL ESTER; CALCIUM ACTIVATED POTASSIUM CHANNEL; CERAMIDE; CILOSTAZOL; CINNAMIC ACID DERIVATIVE; CINNAMYL 3,4 DIHYDROXY ALPHA CYANOCINNAMATE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; ESTROGEN RECEPTOR; FULVESTRANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROLACTIN; SPHINGOMYELIN; SQUAMOCIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANNONACEAE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL CULTURE; CELL FUNCTION; CHANNEL GATING; CULTURE MEDIUM; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME INHIBITION; GENE ACTIVATION; HUMAN; HYPOPHYSIS CELL; MEMBRANE DEPOLARIZATION; NONHUMAN; PIGMENT EPITHELIUM; POTASSIUM CURRENT; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SMOOTH MUSCLE FIBER; STRUCTURE ANALYSIS;

ANIMALS; FURANS; HUMANS; LACTONES; POTASSIUM CHANNELS, CALCIUM-ACTIVATED;

EID: 33744489322     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802606777323764     Document Type: Review

References (62)

1. Kaczorowski, G. J.; Knaus, H. G.; Leonard, R. J.; McManus, O. B.; Garcia, M.L. High Conductance Calcium-Activated Potassium Channels: Structure, Pharmacology, and Function. J. Bioenerg. Biomembr. 1996, 28, 255-267.
2. + Channels to Hyperpolarizing After-Potentials and Discharge Pattern in rat Supraoptic Neurons. J. Neuroendocrinol. 2004, 16, 577-588.
3. + Channel Superfamily. News Physiol. Sci. 1998, 13, 112-117.
4. + Channels in Vascular Smooth Muscle during Hypertension. J. Clin. Invest. 2003, 112, 717-724.
5. Nishimaru, K.; Eghbali, M.; Lu, R.; Marijic, J.; Stefani, E.; Toro, L. Functional and Molecular Evidence of MaxiK Channel Beta-1 Subunit Decrease with Coronary Artery Ageing in the Rat. J. Physiol. 2004, 559, 849-862.
6. + Channel Deficiency. Proc. Natl. Acad. Sci. USA 2004, 101, 9474-9478.
7. + Channel. J. Biol. Chem. 2004, 279, 36746-36752.
8. Duret, P.; Hocquemiller, R.; Gantier, J. C.; Figadere, B. Semisynthesis and Cytotoxicity of Amino Acetogenins and Derivatives. Bioorg, Med. Chem. 1999, 7, 1821-1826.
9. Raynaud, S.; Nemati, F.; Miccoli, L.; Michel, P.; Poupon, M. F.; Fourneau, C.; Laurens, A.; Hocquemiller, R. Antitumor Effects of Squamocin on Parental and Multidrug Resistant MCF-7 (Human Breast Adenocarcinoma) Cell Lines. Life Sci. 1999, 65, 525-533.
10. Nakanishi, Y.; Chang, F. R.; Liaw, C. C.; Wu, Y. C.; Bastow, K. F.; Lee, K. H. Acetogenins as Selective Inhibitors of the Human Ovarian 1A9 Tumor Cell Line. J. Med. Chem. 2003, 46, 3185-3188.
11. Zhu, X. F.; Liu, Z. C.; Xie, B. F.; Li, Z. M.; Feng, G. K.; Xie, H. H.; Wu, S. J.; Yang, R. Z.; Wei, X. Y.; Zeng, Y. X. Involvement of Caspase-3 Activation in Squamocin-Induced Apoptosis in Leukemia Cell Line HL-60. Life Sci. 2002, 70, 1259-1269.
12. + Current in Cultured Smooth Muscle Cells of Human Coronary Artery. Chem. Res. Toxicol. 2003, 16, 15-22.
13. Ko, F. N.; Wu, C. C.; Kuo, S. C.; Lee, F. Y.; Teng, C. M. YC-1, A Novel Activator of Platelet Guanylate Cyclase. Blood 1994. 84, 4226-4233.
14. 3 Cells. Neuropsychopharmacology 2000, 23, 676-689.
15. Wu, C. H.; Chang, W. C.; Chang, G. Y.; Kuo, S. C.; Teng, C. M. The Inhibitory Mechanism of YC-1, a Benzyl Indazole, on Smooth Muscle Cell Proliferation: An in Vitro and in Vivo Study. J. Pharmacol. Sci. 2004, 94, 252-260.
16. Hsiao, G.; Huang, H. Y.; Fong, T. H.; Shen, M. Y.; Lin, C. H.; Teng, C.M.; Shen, J. R. Inhibitory Mechanisms of YC-1 and PMC in the Induction of iNOS Expression by Lipoteichoic Acid in RAW 264.7 Macrophages. Biochem. Pharmacol. 2004, 67, 1411-1419.
17. Wang, S. W.; Pan, S. L.; Guh, J. H.; Chen, H. L.; Huang, D. M.; Chang, Y. L.; Kuo, S. C.; Lee, F. Y.; Teng, C. M. YC-1 Exhibits a Novel Antiproliferative Effect and Arrests the Cell Cycle in G0-G1 in Human Hepatocellular Carcinoma Cells. J. Pharmacol. Exp. Ther. 2004, [Epub ahead of print].
18. ca Channels. FASEB J. 2004, 18, 1382-1391.
19. Shimda, H.; Grutzner, J. B.; Kozlowski, J. F.; McLaughin, J. L. Membrane Conformations and Their Relation to Cytotoxicity of Asimicin and Its Analogues. Biochemistry 1998, 37, 854-866.
20. 2+ Complexes of Annonceous Acetogenins. J. Org. Chem. 1997, 62, 4811-4815
21. Arndt, S.; Emde, U.; Baurie, S.; Friedrich, T.; Grubert, L.; Koert, U. Quinone-Annonaceous Acetogenins: Synthesis and Complex I Inhibition Studies of a New Class of Natural Product Hybrids. Chemistry 2001, 7, 993-1005.
22. Mathias, S.; Pena, L. A.; Kolesnick, R. N. Signal Transduction of Stress via Ceramide. Biochem. J. 1998, 335, 465-480.
23. Colombaioni, L.; Garcia-Gil, M. Sphingolipid Metabolites in Neural Signaling and Function. Brain Res. Brain Res. Rev. 2004, 46, 328-355.
24. Lavrentiadou, S. N.; Chan, C.; Kawcak, T.; Ravid, T.; Tsaba, A.; van der Vliet, A.; Rasooly, R.; Goldkorn, T. Ceramide-Mediated Apoptosis in Lung Epithelial Cells is Regulated by Glutathione. Am. J. Respir. Cell. Mol. Biol. 2001, 25, 676-684.
25. Barak, A.; Morse, L. S.; Goldkorn, T. Ceramide: A Potential Mediator of Apoptosis in Human Retinal Pigment Epithelial Cells. Invest. Ophthalmol. Vis. Sci. 2001, 42, 247-254.
26. 3 Lactotrophs. Endocrinology 2001, 142, 4785-4794.
27. Sheu, S. J.; Wu, S. N. Mechanism of Inhibitory Actions of Oxidizing Agents on Calcium-Activated Potassium Current in Cultured Pigment Epithelial Cells of the Human Retina. Invest. Ophthalmol. Vis. Sci. 2003, 44, 1237-1244.
28. + Current in Prolactin Secretion from Ra Lactotrophs. Mol. Cell. Endocrinol. 1999, 148, 37-45.
29. 3 Lactotrophs. Neuropharmacology 2000, 39, 1788-1799.
30. Ito, Y.; Sato, S.; Ohashi, T.; Nakayama, S.; Shimokata, K.; Kume, H. Reduction of Airway Anion Secretion via CFTR in Sphingomyelin Pathway. Biochem. Biophys. Res. Commun. 2004, 324, 901-908.
31. 3 Cells. Mol. Cell. Endocrinol. 2004, 218, 175-183.
32. Robertson, J. F.; Harrison, M. Fulvestrant: Pharmacokinetics and Pharmacology. Br. J. Cancer 2004, 90 (Suppl 1), S7-S10.
33. 2+ Channels in Smooth Muscle Cells. FASEB J. 1998, 646, 613-619.
34. + Channels in Smooth Muscle. Br. J. Pharmacol. 2002, 36, 961-964.
35. ca Channel Activity in Cultured Endothelial Cells of Human Coronary Artery. Biochem. Pharmacol. 2003, 66, 2053-2063.
36. 2+ Sensitivity-Regulating β Subunit FASEB J. 2000, 14, 885-894.
37. Newton, C. J.; Trapp, T.; Pagotto, U.; Renner, U.; Buric, R.; Stalla, G. K. The Oestrogen Receptor Modulates Growth of Pituitary Tumour Cells in the Absence of Exogenous Oestrogen. J. Mol. Endocrinol. 1994, 12, 303-312.
38. Weaver, A. K.; Liu, X.; Sontheimer, H. Role for Calcium-Activated Potassium Channels (BK) in Growth Control of Human Malignant Glioma Cells. J. Neurosci. Res. 2004, 78, 224-234.
39. Grunberger, D.; Banerjee, R.; Eisinger, K.; Oltz, E. M.; Efros, L.; Caldwell, M.; Estevez, V.; Nakanishi, K. Preferential Cytotoxicity on Tumor cells by Caffeic Acid Phenethyl Ester Isolated from Propolis. Experientia 1988, 44, 230-232.
40. Natarajan, K.; Singh, S.; Burke, T. R. Jr.; Grunberger, D.; Aggarwal, B. B. Caffeic Acid Phenethyl Ester is a Potent and Specific Inhibitor of Activation of Nuclear Transcription Factor NF-κB. Proc. Natl. Acad. Sci. USA 1996, 93, 9090-9095.
41. Joo, J. H.; Kim, J. H.; Lee, Y.; Yoon, S. Y.; Kim, J. H.; Paik, S. G.; Choe, I. S. Involvement of NF-kappaB in the Regulation of S100A6 Gene Expression in Human Hepatoblastoma Cell Line HepG2. Biochem. Biophys. Res. Commun. 2003, 307, 274-280.
42. Nagaoka, T.; Banskota, A. H.; Tezuka, Y.; Saiki, I.; Kadota, S. Selective Antiproliferative Activity of Caffeic Acid Phenethyl Ester Analogues on Highly Liver-Metastatic Murine Colone 26-L5 Carcinoma Cell Line. Bioorg. Med. Chem. 2002, 10, 3351-3359.
43. Wei, X.; Zhao, L.; Ma, Z.; Holtzman, D. M.; Yan, C.; Dodel, R. C.; Hampel, H.; Oertel, W.; Farlow, M. R.; Du, Y. Caffeic Acid Phenethyl Ester Prevents Neonatal Hypoxic-Ischaemic Brain Injury. Brain 2004, 127, 2629-2635.
44. Danthi, S.; Enyeart, J. A.; Enyeart, J. J. Caffeic Acid Esters Activate TREK-1 Potassium Channels and Inhibit Depolarization-Dependent Secretion. Mol. Pharmacol. 2004, 65, 599-610.
45. 3 Cells. J. Biol. Chem. 2004, 279, 26885-26892.
46. Massaeli, H.; Sobrattee, S.; Pierce, G. N. The Importance of Lipid Solubility in Antioxidants and Free Radical Generating Systems for Determining Lipoprotein Peroxidation. Free Radic. Biol. Med. 1999, 26, 1524-1530.
47. Dolmetsch, R. E.; Xu, K.; Lewis, R. S. Calcium Oscillations Increase the Efficiency and Specificity of Gene Expression. Nature 1998, 392, 933-936.
48. Tang, X. D.; Garcia, M. L.; Heinemann, S. H.; Hoshi, T. Reactive Oxygen Species Impair Slo1 BK Channel Function by Altering Cysteine-Mediated Calcium Sensing. Nature Struct. Mol. Biol. 2004, 11, 171-178.
49. Bhimani, R. S.; Troll, W.; Grunberger, D.; Frenkel, K. Inhibition of Oxidative Stress in HeLa Cells by Chemopreventive Agents. Cancer Res. 1993, 53, 4528-4533.
50. Schror, K. The Pharmacology of Cilostazol. Diabet Obes. Metab. 2002, 4 (Suppl 2), S14-S19.
51. Kambayshi, J.; Liu, Y.; Sun, B.; Shakur, Y.; Yoshitake, M.; Czerwiec, F. Cilostazol as Unique Antithrombotic Agent. Curr. Pharm. Des. 2003, 9, 2289-2308.
52. Barnett, A. H.; Bradbury, A. W.; Brittenden, J.; Crichton, B.; Donnelly, R.; Homer-Vanniasinkam, S.; Mikhailidis, D. P.; Stansby, G. The Role of Cilostazol in the Treatment of Intermittent Claudication. Curr. Med. Res. Opin. 2004, 20, 1661-1670.
53. Hong, K. W.; Kim, K. Y.; Shin, H. K.; Lee, J. H.; Choi, J. M.; Kwak, Y. G.; Kim, C. D.; Lee, W. S.; Rhim, B. Y. Cilostazol Prevents Tumor Necrosis Factor-α-Induced Cell Death by Suppression of Phosphatase and Tension Homolog Deleted from Chromosome 10 Phosphorylation and Activation of Akt/cyclic AMP Response Element-Binding Protein Phosphorylation. J. Pharmacol. Exp. Ther. 2003, 306, 1182-1190.
54. 3 Cells and Pheochromocytoma PC12 Cells. Endocrinology 2004, 145, 1175-1184.
55. 2+ Waves in Immortalized Hypothalamic (GT1-1) Neurons. J. Neurophysiol. 1999, 82, 429-435.
56. Haug, T. M.; Hafting, T.; Sand, O. Inhibition of BK Channels Contributes to the Second Phase of the Response to TRH in Clonal Rat Anterior Pituitary Cells. Acta Physiol. Scand. 2004, 180, 347-357.
57. Watanabe, K.; Ikeda, S.; Komatsu, J.; Inaba, S.; Suzuki, J.; Sueda, S.; Funada, J.; Kitakaze, M.; Sekiya, M. Effect of Cilostazol on Vasomotor Reactivity in Patients with Vasospastic Angina Pectoris. Am. J. Cardiol. 2003, 92, 21-25.
58. Kuchulakanti, P.; Waksman, R. Therapeutic Potential of Oral Antiproliferative Agents in the Prevention of Coronary Restenosis. Drugs 2004, 64, 2379-2388.
59. Liu, P.; Xi, Q.; Ahmed, A.; Jaggar, J. H.; Dopico, A. M. Essential Role for Smooth Muscle BK Channels in Alcohol-Induced Cerebrovascular Constriction. Proc. Natl. Acad. Sci. USA 2004, 101, 18217-18222.
60. Tohma, T.; Shimabukuro, M.; Oshiro, Y.; Yamakawa, M.; Shimajiri, Y.; Takasu, N. Cilostazol, a Phosphodiesterase Inhibitor, Reduces Microalbuminuria in the Insulin-Resistant Otsuka Long-Evans Tokushima Fatty Rat. Metabolism 2004, 53, 1405-1410.
61. + channels: Physiological Role and Pharmacology. Curr. Med. Chem. 2003, 10, 649-661.
62. Wu, S. N.; Chao, C. T. Inhibitory Effect of Ethanol on Voltage Dependent Potassium Currents in Single Aortic Smooth Muscle Cells. Kaohsiung J. Med. Sci. 1995, 11, 514-520.